Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
8 Sep 2025 Job Information Organisation/Company University of Oslo Research Field Medical sciences » Cancer research Researcher Profile Established Researcher (R3) Positions Research Support
-
States) Background information on all DC positions and the SHIELD Doctoral Network is available on: http://www.shield-dn.eu https://euraxess.ec.europa.eu/jobs/hosting/16-phd-positions-available-highly-motivated-early
-
powered by: Cookie Information Nettsiden bruker cookies Vi ønsker at du skal være trygg når du bruker dette nettstedet. Vi benytter cookies for å sikre at du får en best mulig brukeropplevelse og
-
background, we will invite at least one applicant from each of these categories to an interview. Contact information For questions about the position: Professor Nina Reiners, Norwegian Centre for Human Rights
-
bioinformatics tools and workflows for gene expression data analysis. Interest in interdisciplinary research at the interface of cell signaling and bone biology. To be employed as a PhD Research Fellow, admission
-
powered by: Cookie Information Nettsiden bruker cookies Vi ønsker at du skal være trygg når du bruker dette nettstedet. Vi benytter cookies for å sikre at du får en best mulig brukeropplevelse og
-
background, we will invite at least one applicant from each of these categories to an interview. Contact information For questions about the position: Professor Nina Reiners, Norwegian Centre for Human Rights
-
powered by: Cookie Information Nettsiden bruker cookies Vi ønsker at du skal være trygg når du bruker dette nettstedet. Vi benytter cookies for å sikre at du får en best mulig brukeropplevelse og
-
with open science practices is an advantage Experience with using Shiny or similar data visualization and exploration tools Experience with data management and/or version control Personal skills Strong
-
vesicles from NK cells Apply for this job See advertisement About the position A full-time phd position (SKO 1017) is available for 3 years in the “Innate Lymphocyte Group” led by professor Marit